Glycomimetics Inc. Stock
Glycomimetics Inc. Stock
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Glycomimetics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Glycomimetics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glycomimetics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -1.090% | 1.501% | 6.242% | -4.991% | 3.525% | 200.937% | -1.306% |
| Krystal Biotech | 1.290% | 6.399% | 17.592% | 14.742% | 32.194% | 183.380% | - |
| Evolus Inc | -1.720% | -2.521% | -4.132% | -50.847% | -44.762% | -12.782% | 90.164% |
Comments
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat